The Viral Hepatitis Action Coalition is a public-private partnership developed by the CDC Foundation. Members of the Viral Hepatitis Action Coalition show a demonstrated commitment to helping CDC make meaningful advances in the prevention, screening and treatment of viral hepatitis. Coalition members help support crucial CDC-led research and programs and amplify CDC’s messages to the public to increase overall awareness of viral hepatitis.
Abbott Laboratories
|
Boehringer Ingelheim
|
Bristol-Myers Squibb
|
CDC Foundation
|
Genetech, A Member of the Roche Group
|
Gilead Sciences, Inc.
|
GlaxoSmithKline
|
Janssen Therapeutics
|
Merck Sharp & Dohme
|
National Viral Hepatitis Roundtable
|
OraSure Technologies
|
Vertex Pharmaceuticals
|